The Immunocompromised State and Opportunistic Infections [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

XI International Vancouver
7 Conference July 7-12, 1996
on AIDS
Ofiia ellite -yposum
he International Conference
on AIDS has served as a timely
forum for the analysis and dissemination of new information about
Human Immunodeficiency Virus
(HIV- 1) and the opportunistic
infections that are the hallmark of
the Acquired Immunodeficiency
Syndrome. After a period of considerable frustration among physicians,
other caregivers, and patients, it is
now apparent that there are important new approaches to the management of the underlying viral disease
and its opportunistic bacterial,
fungal, and viral complications.
The immunocompromised
state and its evolution has been the
subject of intense study and there
is evolving knowledge about the
phenomenon of long-term survival.
One of the most gratifying developments has been in the area of preventing serious opportunistic complications. Quality of life appears
enhanced and, most gratifyingly, the
prophylaxis of some opportunistic
infections is associated with
improved survival.
Our meeting must be selective,
but its purpose will be to review
some important new information
on the immunocompromised state
associated with AIDS and the management of opportunistic infections.
Welcome to Vancouver, Canada!
Sincerely yours,

Lowell S. Young, MD
Director, KIAID
This symposium is sponsored by an
unrestricted educational grant from Pfizer Inc

AN
The symposium will be held in the MacKenzie Room of the
Waterfront Centre Hotel from 7:00 to 9:30 PM on Tuesday, July 9, 1996

6:15 PM
7:00
7:05
7:30
7:55

Reception
Malaspina Room
Opening Remarks
Lowell S. Young, MD, Chairman
Director, Kuzell Institute
San Francisco, CA
Epidemiology of Opportunistic Infections
Robert Horsburgh, MD
Professor of Medicine
Emory University
Atlanta, GA
Managing Opportunistic Candida Infections
Vince Pons, MD
Former Clinical Professor of Medicine
University of California
San Francisco, CA
Combination Therapies in Cryptococcal Meningitis
Robert Larsen, MD
Associate Chairman of Medicine
Associate Professor of Medicine
University of Southern California School of Medicine
Los Angeles, CA

8:20
8:45
9:15

Mycobacterium Avium Complex:
Current Options in Prophylaxis
Richard Chaisson, MD
Director, Moore Clinic
Associate Professor of Medicine
Johns Hopkins Hospital
Baltimore, MD
Long-Term Survival and Quality of Life
Jay Levy, MD
Professor of Medicine
Cancer Research Institute
University of California
San Francisco, CA
Closing Remarks/Questions and Answers
Lowell S. Young, MD, Chairman

O
0
0
N.-"
SLO

Yor ttndnc i wlcme bspaeS slii-d